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In Brief
Nutrient supply from the host cell is
essential for the survival of obligate intra-
cellular bacteria. The tumor suppressor
p53 plays a crucial role in host cell meta-
bolism. Siegl et al. now highlight the role
of p53 in host cell defense during infec-
tion by Chlamydia and show how this
pathogen counteracts p53 for survival.
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Obligate intracellular bacteria depend entirely on nu-
trients from the host cell for their reproduction. Here,
we show that obligate intracellular Chlamydia down-
regulate the central tumor suppressor p53 in human
cells. This reduction of p53 levels is mediated
by the PI3K-Akt signaling pathway, activation of
HDM2, and subsequent proteasomal degradation
of p53. The stabilization of p53 in human cells
severely impaired chlamydial development and
caused the loss of infectious particle formation.
DNA-damage-induced p53 interfered with chla-
mydial development through downregulation of
the pentose phosphate pathway (PPP). Increased
expression of the PPP key enzyme glucose-6-phos-
phate dehydrogenase rescued the inhibition of chla-
mydial growth induced by DNA damage or stabilized
p53. Thus, downregulation of p53 is a key event in the
chlamydial life cycle that reprograms the host cell to
create a metabolic environment supportive of chla-
mydial growth.INTRODUCTION
Chlamydia trachomatis is the cause of trachoma, the leading
infectious blinding disease worldwide, and the predominant
sexually transmitted bacterial pathogen that causes pelvic in-
flammatory disease and ectopic pregnancy. Chlamydia have a
unique biphasic developmental life cycle consisting of infectious,
nonreplicative elementary bodies (EBs) and noninfectious, repli-
cation-competent reticulate bodies (RBs). Sequence analysis of
Chlamydia’s small (1.04 Mb) genome has revealed that
numerous metabolic pathways in C. trachomatis are incomplete
or entirely missing (Stephens et al., 1998). Chlamydia overcome
their reduced metabolic capacity by taking up nutrients such as
nucleotides, amino acids, and lipids from intact and living host
cells (Saka and Valdivia, 2010) during their entire developmental
cycle.
As part of its intracellular lifestyle, Chlamydia actively inter-
feres with host cell apoptosis (Fan et al., 1998) to protect its repli-918 Cell Reports 9, 918–929, November 6, 2014 ª2014 The Authorscation niche. These antiapoptotic strategies prevent cell death
induced by death receptor activation, diverse cellular stresses
(Fan et al., 1998), and double-stranded RNA, which imitates viral
infection (Bo¨hme et al., 2010). Since defective apoptosis
signaling is a hallmark of cancer cells and Chlamydia infection
has been connected to ovarian cancer (Shanmughapriya et al.,
2012), it has been hypothesized that Chlamydia-induced inhibi-
tion of apoptosis may support the survival of damaged cells
that are prone to transform into cancer cells.
Several bacteria have been shown to cause damage to host
cell DNA during infection (Bergounioux et al., 2012; Elsen et al.,
2013; Nougayre`de et al., 2006; Toller et al., 2011; Vielfort et al.,
2013). One recent report demonstrated the induction of DNA
double-strand breaks (DSBs) duringChlamydia infection (Chum-
duri et al., 2013). Interestingly, despite severe DNA damage, a
normal DNA damage response, including repair, is not observed
in Chlamydia-infected cells due to inhibition of the recruitment of
pATM and p53BP to damaged DNA.
Here, we investigated the role of the tumor suppressor p53
during Chlamydia infections and its impact on the DNA damage
response. As DSBs predominantly occurred at chromosomal
ends, causing telomere shortening, host cells were subjected
to cell-cycle arrest or senescence. However,Chlamydia infection
induced the degradation of p53 and repair of damaged DNA in
primary human cells. Depletion of p53 in infected cells prevented
repression of the pentose phosphate pathway (PPP), which is
responsible for DNA damage repair, and ensured the provision
of metabolites that are essential for chlamydial growth. Our
data provide a link to a p53-dependent antibacterial mechanism
that limits the metabolite resources required for the survival of
obligate intracellular bacteria and promotes host cell death in
response to infection-induced oxidative stress and genotoxicity.RESULTS
p53 Is Downregulated in Chlamydia-Infected Human
Cells
Chlamydia infection induces DSBs (Chumduri et al., 2013) and
transient telomere shortening (Prusty et al., 2013). Upon detec-
tion of single-strand breaks, DSBs, or telomere shortening, the
tumor suppressor p53 is stabilized and induces cell-cycle
arrest and the DNA damage response, cellular senescence, or
apoptosis (Ba´lint and Vousden, 2001). In the presence of a
Figure 1. p53 Is Downregulated in Chlamydia-Infected Human Cells
(A) HUVECswere infectedwithC. trachomatis for different time periods, and p53 and chlamydial Hsp60 were detected by immunoblotting. GAPDHwas used as a
loading control. Fold-change values of p53 were derived by normalization to GAPDH and are indicated below the blots.
(B and C) HUVECs were infected with C. trachomatis serotype L2 and serotype D (B) and C. pneumoniae (C).
(D) HUVECs were infected with C. muridarum for different time periods and p53 was detected by immunoblotting.
(E) Epithelial cells of human fallopian tube fimbriae (hfimb) were infected with C. trachomatis for different time periods and p53 was detected by immunoblotting.
(F) p53 is not downregulated in MEFs. MEFs were infected with C. trachomatis for different time periods and processed as described above.
(G) MEFs were infected with C. muridarum for different time periods and p53 was detected by immunoblotting.Chlamydia infection, even high doses of the DNA-damage-
inducing drug etoposide could not induce apoptosis (Fig-
ure S1A). Etoposide-induced apoptosis is p53 dependent and
results in outer mitochondrial membrane permeabilization
(Green and Kroemer, 2009). Since Chlamydia was clearly able
to prevent this, we suspected manipulation of p53-induced
signaling pathways.
We first monitored p53 stabilization in primary human umbili-
cal vein endothelial cells (HUVECs) afterC. trachomatis infection.
Astonishingly, p53 levels decreased around 10–16 hr postinfec-
tion (Figure 1A). Heat inactivation of Chlamydia prior to infection
prevented the reduction of p53 levels (Figure S1B), demon-
strating that live bacteria, and not the sensing of pathogen-asso-
ciatedmolecular patterns such as bacterial lipopolysaccharides,
are required for p53 downregulation. Chlamydia infection alsoCreduced p53 in HeLa cells, which, in contrast tomost tumor cells,
express wild-type p53 (Figure S1C). Downregulation of p53 is a
general consequence of Chlamydia infection, since it is also
observed in cells infected with a different C. trachomatis serovar
(Figure 1B), the human pathogenic species C. pneumoniae (Fig-
ure 1C), and the mouse-specific strain C. muridarum (Figure 1D).
To confirm that C. trachomatis induced p53 downregulation in
naturally infected tissues, we prepared epithelial cells from
biopsies of human fimbriae of the fallopian tube (hfimb) and
monitored p53 levels upon chlamydial infection. p53 was
strongly reduced in these primary cells (Figure 1E). Concomi-
tantly with reduced p53 protein levels, DNA binding of p53,
which is indicative of its transcriptional activity, decreased dur-
ing infection in a time-dependent manner (Figure S1D). Addition-
ally, we infected murine embryonic fibroblasts (MEFs) withell Reports 9, 918–929, November 6, 2014 ª2014 The Authors 919
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C. trachomatis andC.muridarum to test whether downregulation
of p53 during Chlamydia infection was species specific or a gen-
eral feature that was independent of the host. Interestingly, p53
levels remained unchanged inMEFs infected withC. trachomatis
(Figure 1F) or C. muridarum (Figure 1G), demonstrating that the
fate of p53 differs fundamentally between infected human and
mouse cells.
Chlamydia Infection Induces p53-Dependent
Cytotoxicity in Mouse Cells
To examine a possible outcome of the differential regulation of
p53 in primary human and mouse cells, we analyzed the viability
of HUVECs, MEFs (p53+/+ or p53/), and (as a second mouse
cell line in addition to MEFs) epithelial cells of murine fimbriae
(mfimb) during C. trachomatis infection (Figures 2A and 2B).
We observed an increased number of necrotic MEFs and
mfimb compared with HUVECs after C. trachomatis infection.
In contrast to this, almost no necrotic cells were found in
p53/ MEFs. To verify that increased cytotoxicity during
C. trachomatis infection of murine cells results in reduced bacte-
rial infection, we infected mfimb, p53/ MEFs, and p53/
MEFs transfected with hemagglutinin (HA)-tagged p53, as well
as HUVECs, with C. trachomatis for 2 days, and used lysates
of these cells for reinfection (Figure 2C). Under these conditions,
onlyChlamydia that passed the developmental cycle will reinfect
and allow progeny quantification (hereafter referred to as infec-
tivity assay). Interestingly, chlamydial progeny formation was
increased in p53/ MEFs compared with chlamydial infectivity
in mfimb and p53/MEFs transfected with HA-p53 (Figure 2C).
In addition to the infectivity assay, one-step growth curves were
generated to characterize the number of inclusion-forming units
and the infectivity rate of C. trachomatis and C. muridarum in
HUVECs, p53+/+ MEFs, and p53/ MEFs. Again, fewer chla-
mydial progeny were recovered from C. trachomatis- and
C. muridarum-infected p53+/+ MEFs compared with p53/
MEFs (Figure S1E). Based on these results, we hypothesized
that p53 plays an important role during Chlamydia infection
and is responsible for restricted infection in mouse cells.
Since increased infection-induced cytotoxicity was clearly
linked to p53 in mouse cells, we next investigated DNA damage
caused by Chlamydia infection in more detail. We developed an
assay, which we call the neutral DNA break (NDB) assay (see
Supplemental Experimental Procedures), that allows one to
differentiate between bacterial and host cell DNA and thus is
suitable for characterizing the type of DNA damage that has
occurred. Since chromosomal and high-molecular-weight chla-
mydial DNA does not migrate into the gel, only extrachromo-Figure 2. Chlamydia Infection Induces p53-Dependent Cytotoxicity in
(A) C. trachomatis infection induces cytotoxicity in epithelial cells of murine fimb
mfimb, p53+/+, and p53/ MEFs were infected with C. trachomatis for 40 hr. An
(B) Early apoptotic cells after 40 hr of Chlamydia infection are displayed in Q4, la
(C) Cytotoxicity in MEFs reduces chlamydial infectivity. Epithelial cells of mfimb,
HUVECs, were infected with C. trachomatis (C.tr.) for 48 hr and chlamydial deve
(D) An NDB assay was carried out using p53+/+ and p53/MEFs infected withC.
(EtBr). Fragmented DNA and DNA within the wells were quantified and used t
Mean ± SEM of three independent experiments is shown; *p < 0.05.
See also Figures S1 and S2.
Csomal and broken DNA becomes separated. Interestingly, we
detected in all cells a single prominent DNA fragment that
migrated into the gel and whose intensity increased in etopo-
side-treated or Chlamydia-infected cells (Figures S2A and
S2B), suggesting that this band represents a major DNA-dam-
age-associated cleaved product of the human genome. South-
ern hybridization identified this band as telomeric DNA, which
is also present in minute amounts as extrachromosomal telo-
meric DNA in most normal cells (Wang et al., 2004). Interestingly,
the telomeric DNA break became prominent only after 24 hr
postinfection (hpi) in HeLa cells (Figure S2A) and even later
(36 hpi), but visibly stronger, in MEFs (Figure S2B). Telomere re-
striction fragment (TRF) analysis validated the results of the NDB
assay in both cell types (Figures S2C and S2D). We observed
complete but transient loss of telomeres in HeLa cells infected
with C. trachomatis (Figure S2C, left panel) or C. pneumoniae
(Figure S2C, right panel). Telomeres were lost in MEFs upon
C. trachomatis infection and were not repaired at all (Figure S2D,
left panel). A similar effect was observed upon C. muridarum
infection of MEFs (Figure S2D, right panel), indicating that the
lack of telomere repair depends on the cell type and not on the
chlamydial strain. Intriguingly, we found decreased DNA dam-
age in p53/ MEFs during Chlamydia infection in comparison
with the p53+/+ MEFs (Figures 2D and S2E), suggesting that
p53 not only functions as a downstream effector of DNA damage
but also inhibits repair of damaged DNA. Increased p53-medi-
ated cytotoxicity may also enhance DNA degradation in infected
cells. Thus, we concluded that the presence of active p53, as
well as severe and prolonged shortening of telomeres, might
be the cause of increased cytotoxicity in Chlamydia-infected
MEFs, suggesting that p53 downregulation plays an important
role in ensuring efficient infection of the host cell.
Downregulation of p53 in Infected Cells Depends on PI3
Kinase and HDM2 Activation
C. trachomatis infection activates the PI3K pathway to stabilize
the antiapoptotic Mcl-1 and cIAP-2 proteins (Rajalingam et al.,
2008). However, activation of this pathway also induces
enhanced degradation of p53 by targeting it for proteasomal-
mediated degradation. To examine the impact of PI3K on p53
downregulation in primary HUVECs, we analyzed PI3K activity
during infection by monitoring phosphorylation of the PI3K sub-
strate Akt at serine 473 (Ser473). In line with previous studies
(Rajalingam et al., 2008; Verbeke et al., 2006), C. trachomatis
infection resulted in increased phosphorylation and activation
of Akt in a multiplicity of infection (moi)- and time-dependent
manner in primary cells (Figures 3A and 3B). Furthermore,Mouse Cells
riae (mfimb) and wild-type MEFs, but not in MEFs deficient of p53. HUVECs,
nexin-V/propidium iodide staining was followed by flow-cytometric analysis.
te apoptotic cells are shown in Q2, and necrotic cells are shown in Q1.
p53/ MEFs, and p53/ MEFs transfected with HA-tagged p53, as well as
lopment was analyzed by an infectivity assay.
trachomatis for different time periods. Gels were stained with ethidium bromide
o determine the relative fragmented DNA level, presented as bar diagrams.
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the PI3K inhibitor LY294002 rescued p53 protein levels (Fig-
ure 3C), indicating a crucial role for the PI3K pathway in infec-
tion-induced p53 degradation. In contrast, infection of MEFs
with C. trachomatis only slightly induced activation of PI3 kinase
(Figure S3A), which explains the constant levels of p53 in in-
fected mouse cells.
HDM2 (the human form of murine double minute 2 [MDM2]) is
the main regulator of p53 protein levels and mediates p53
degradation via its E3 ligase activity, which catalyzes the ubiq-
uitination of p53. Akt directly activates HDM2 by phosphoryla-
tion of Ser166 and Ser186 (Ogawara et al., 2002), and in
agreement with this, we found increased phosphorylated
HDM2 in infected cells (Figures 3A and 3B). HDM2 binds to
p53 in the nucleus, mediates its export to the cytoplasm, and
catalyzes the formation of ubiquitin chains on p53. To block
the interaction between HDM2 and p53, we used Nutlin-3, a
cis-imidazoline that specifically binds to a pocket in HDM2
and thereby inhibits its interaction with the N terminus of p53
(van Leeuwen et al., 2011). Application of Nutlin-3 at 10 mM re-
sulted in a strong stabilization of p53 protein levels that could
not be overcome by Chlamydia infection (Figure 3D). To rule
out any off-target effects of Nutlin-3 and to confirm HDM2 as
a target of Chlamydia-induced p53 degradation, we silenced
HDM2 expression using small hairpin RNAs (shRNAs). Depletion
of HDM2 expression interfered with p53 downregulation in in-
fected cells as well (Figure 3E). Furthermore, infection-induced
p53 downregulation was prevented by treating the cells with
the proteasomal inhibitor MG-132 (Figure 3F). We confirmed
the inhibition of p53 function by analyzing two important tran-
scriptional targets of p53: the cell-cycle arrest protein p21 and
the proapoptotic protein Puma. As expected, the protein levels
of both p53 targets decreased during Chlamydia infection (Fig-
ure 3G). In addition, the RNA levels of Puma decreased after
C. trachomatis infection (Figure S3B), consistent with a func-
tional downregulation of p53.
Stabilization of p53 Interferes with Chlamydial
Development
The results obtained so far strongly indicated that the downregu-
lation of p53 during chlamydial infection was promoted by the
pathogen rather than an antibacterial response of the host cell
to limit replication of Chlamydia. In line with this notion, HeLa
cells with stable silencing of p53 expression (HeLa-p53-KD)
using shRNAs were infected with the same efficiency as theFigure 3. Downregulation of p53 in Infected Cells Depends on PI3 Kina
(A) C. trachomatis (C.tr.) infection induces phosphorylation of Akt and HDM2. HU
time periods.
(B) p-HDM2 (Ser166), HDM2, p-Akt (Ser473), Akt, cHsp60, and p53 were detect
(C) Inhibition of PI3K blocks p53 depletion. HUVECs were treated with 10 mM of t
different time periods. p53, pAkt, and Akt were detected by immunoblotting.
(D) Inhibition of HDM2 results in p53 stabilization. HUVECs were treated with 5 and
(C.tr.) for 24 hr. p53, chlamydial Hsp60, and chlamydial OmpA were detected by
(E) Silencing of HDM2 resulted in stabilization of p53. HDM2 was silenced by
knockdown efficiency was checked with an antibody against HDM2.
(F) Inhibition of the proteasome prevents p53 degradation. HUVECs were treate
C. trachomatis (C.tr.) for 24 hr.
(G) HUVECs were infected with C. trachomatis (C.tr.) for different time periods. p
See also Figure S3.
Cwild-type cells (HeLa-pLVTHM) (Figure S3C). Furthermore,
Chlamydia propagated in both HeLa-pLVTHM- and HeLa-p53-
KD-generated infectious EBs with the same efficiency (Figures
S3D and S3E), suggesting a benefit of p53 downregulation for
the pathogen rather than the host.
To investigate whether elevated p53 levels affect chlamydial
development, we increased the protein stability of p53 in in-
fected HUVECs using Nutlin-3 and etoposide. Indirect effects
of these inhibitors on Chlamydia could be excluded, since prein-
cubation of chlamydial EB with Nutlin-3 or etoposide for 30 min
did not affect infection efficiency (Figure S3F), inclusion forma-
tion, or infectivity. Pretreatment of cells with the DNA-damaging
agent etoposide at 50 mM prior to infection increased p53 levels
(Figure S3G). HUVECs pretreated with etoposide to activate p53
and infected withC. trachomatis showed a decline in p53 protein
levels after 18 hr of infection (Figure 4A). Surprisingly, inclusion
formation was strongly impaired in these cells. Confocal and
electron microscopy revealed that Chlamydia were able to infect
cells in the presence of high levels of p53, since individual bac-
teria could be seen inside the cell (Figures 4B and 4C); however,
the Chlamydia appeared to be in a persistent, nonreplicative
form (Figures 4B and 4C). The same effect on Chlamydia inclu-
sion formation was observed in the presence of the HDM2 inhib-
itor Nutlin-3, which also stabilized p53 (Figures 4D and 4E). High
levels of p53 not only affected inclusion formation but also
caused a loss of infectivity, as no infectious Chlamydia could
be obtained from cells grown with stabilized p53 (Figure 4F).
An effect similar to that observed with Nutlin-3 was seen after
cells were treated with the PI3K inhibitor LY294002 before Chla-
mydia infection (data not shown), which also caused increased
stabilization of p53 (Figure 3C). Unexpectedly, removal of
Nutlin-3 at 16 hpi resulted in complete recovery of chlamydial in-
clusion formation within several hours (Figure 4G) and the suc-
cessful completion of the chlamydial life cycle, since infectivity
of Chlamydia was restored under these conditions (Figure 4H).
In addition to the role of DNA damage in chlamydial growth inhi-
bition, p53 might directly function as a suppressor of Chlamydia
development. To demonstrate that etoposide affects chlamydial
development via stabilization of p53, we made use of a set of
isogenic HCT116 cells, which differ only in their p53 status
(Bunz et al., 1998). Etoposide treatment of the parental
HCT116 line, which contains wild-type p53 (HCT116 p53+/+),
strongly repressed chlamydial development, whereas the same
treatment of the p53-deficient line (HCT116 p53/) allowedse and HDM2 Activation
VECs were infected with C. trachomatis at different moi values or for different
ed by immunoblotting and GAPDH was used as loading control.
he PI3K inhibitor LY294002 followed by infection with C. trachomatis (C.tr.) for
10 mMof the HDM2 inhibitor Nutlin-3, followed by infection withC. trachomatis
immunoblotting. GAPDH was used as the loading control.
lentivirus-mediated transduction of shRNA constructs in HUVECs and the
d with 3 mM of the proteasome inhibitor MG-132, followed by infection with
21, Puma, and p53 were detected by immunoblotting.
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chlamydial growth (Figure S3H). These results demonstrate a
direct inhibitory effect of p53 on chlamydial development.
Glycolysis Is Not a Major p53 Target that Is Essential for
Chlamydial Development
p53 is a major suppressor of tumor growth (Vousden and Prives,
2009) and affects multiple pathways, such as the cell cycle, DNA
repair, and apoptosis (Levine and Oren, 2009). In more than half
of all human cancers, p53 is either mutated or downregulated,
emphasizing its role as a major tumor suppressor. However, a
cell-intrinsic antibacterial role of p53 has not been established
so far. Since etoposide treatment failed to induce efficient
apoptosis in infected cells (Figure S1A), we reasoned that the
antichlamydial effect of p53 might not depend on its function
as an inducer of cell death. Recently, an important role for p53
in the regulation of metabolic pathways, including glycolysis,
was demonstrated (Madan et al., 2011). As obligate intracellular
bacteria, Chlamydia depend on the uptake of glucose from the
host cells (Omsland et al., 2012), and p53 has been shown to
downregulate glucose transport and glycolysis (Schwartzen-
berg-Bar-Yoseph et al., 2004). We observed upregulation of
glucose transporter 1 (Glut1) after Chlamydia infection and
downregulation after etoposide treatment (Figure S3I). However,
we did not observe decreased expression of Glut4 after etopo-
side treatment (Figure S3I). p53 negatively regulates glycolysis
through activation of TIGAR (a direct inhibitor of cellular fruc-
tose-2,6-bisphosphate levels) (Bensaad et al., 2006). Indeed,
we found that TIGAR was downregulated in Chlamydia-infected
cells (Figure S3J) and slightly stabilized after etoposide treat-
ment (Figure S3J), suggesting that TIGAR downregulation de-
pends on p53 degradation. However, supplementation of the
growth medium with cell-permeable sodium pyruvate, one of
the major end products of glycolysis, to overcome the TIGAR-
mediated block in glycolysis did not rescue chlamydial growth
(Figure S3K). It is still possible that intermediates of glycolysis
(e.g., amino acids) might be essential for chlamydial growth
in vivo. However, under cell culture conditions, amino acids are
supplied in the culture medium, suggesting that other p53-
dependent metabolic pathways are important for Chlamydia
growth under these conditions.Figure 4. Stabilization of p53 Adversely Affects C. trachomatis Inclusio
(A) HUVECs were treated with etoposide (50 mM) for 6 hr to induce p53 stabiliza
sequently infected with C. trachomatis (C.tr.) at an moi of 1 for 30 hr or left uninf
detected by immunoblotting. Fold-change values were derived by normalization
(B) Upregulation of p53 results in impaired chlamydial inclusion formation. Cells w
against chlamydial Hsp60 (cHsp60) and Draq5 to visualize nuclei, and analyzed
(C) Transmission electron microscopy was performed to investigate the ultrastruc
(a), treated with 50 mM etoposide (b), or treated with etoposide for 6 hr followed b
Bars represent 2 mm at 3,0003 (a–c) and 7,0003 (d) magnification. RB, reticulat
(D) HUVECswere treatedwith 10 mMof Nutlin-3 and infectedwithC. trachomatis (C
fold-change values were determined by normalization to GAPDH.
(E) To show impaired inclusion formationafter addition ofNutlin-3, cells infectedwith
(F) High levels of p53 result in loss of chlamydial infectivity. HeLa229 cells infec
transferred to fresh cells to monitor chlamydial infectivity. Infectivity was determ
(G) Immunofluorescence analysis of restored chlamydial inclusion formation after r
C. trachomatis (C.tr.) for 16 hr. The medium was replaced and cells were fixed a
(H) Nutlin-3-induced loss of infectivity can be rescued by removing Nutlin-3. HUV
for 48 hr. In one set of cells, Nutlin-3 containing media was replaced by fresh medi
were used to determine chlamydial infectivity by secondary infection of fresh ce
CGlucose-6-P-Dehydrogenase Is the p53 Target that Is
Critical for Chlamydial Development
The PPP is another glycolytic pathway that is downregulated by
stabilized p53. One of the major p53 targets in the PPP is
glucose-6-P-dehydrogenase (G6PD) (Jiang et al., 2011), the first
and rate-limiting enzyme of the PPP that is involved in NADPH
production.We selectively inhibited the PPP by treating HUVECs
with 6-aminonicotinamide (6-AN), a well-established inhibitor of
the NADP+-dependent 6-phosphogluconate dehydrogenase,
and observed a dose-dependent strong reduction of chlamydial
growth (Figure 5A). p53 was previously shown to inhibit G6PD
activity by binding directly to G6PD and preventing active dimer
formation (Jiang et al., 2011). To further characterize the nature of
the p53-mediated antichlamydial activity, we usedp53/H1299
cells and H1299 cells stably expressing tumor-associated p53
mutants, which are mostly missense mutations that affect p53
function and fail to inhibit G6PD activity (Jiang et al., 2011). We
transiently transfected H1299 cells with p53 and observed a
strong reduction of chlamydial infectivity and impaired inclusion
formation (Figures 5B and 5C), further supporting a direct role for
p53 in the suppression of Chlamydia growth. Infection of p53/
H1299 cells or H1299 cells expressing high levels of mutant p53
R175H and p53 R273H (Petitjean et al., 2007) allowed partial
chlamydial growth recovery (Figure S4A). These results indicated
that impaired chlamydial growth was possibly caused by p53-
mediated inhibition of G6PD and subsequent inhibition of the
PPP. Indeed, G6PD activity was strongly reduced after overex-
pression of p53, but not of the mutants p53 R175H and p53
R273H, in noninfected and infected cells (Figure 5D). Interest-
ingly, G6PD activity upon etoposide treatment was rescued in
noninfected and infected p53/ H1299, p53 R175H, and p53
R273H H1299 cells (Figure 5D), demonstrating that p53 is a
main inhibitor of G6PD activity. As a consequence, we expected
that overexpression of G6PD would overcome the inhibitory
activity of stabilized p53 and rescue chlamydial development.
In agreement, overexpression of G6PD rescued chlamydial
development in etoposide- and Nutlin-3-treated cells in a dose-
dependent manner (Figures 5E and S4B), strengthening the
hypothesis that p53-mediated inhibition of G6PD is the crucial
point for the antichlamydial activity of p53. However, rescue ofn Formation and Infectivity
tion. Cells were washed with fresh medium to remove the inhibitor and sub-
ected. Cells were lysed at the indicated time points, and p53 and Hsp60 were
to GAPDH.
ere treated and infected as described in (A), fixed and stained with an antibody
by immunofluorescence analysis. Scale bar, 20 mm.
ture of single dispersed inclusions. HUVECs were infected with C. trachomatis
y C. trachomatis infection (c and d) for 24 hr. Panel (d) is a magnification of (c).
e body; EB, elementary body; AB, aberrant body.
.tr.) for 24 hr. p53 and chlamydial Hsp60were detected by immunoblotting and
C. trachomatis (C.tr.) for 24hrwere treatedasdescribed in (B). Scale bar, 20mm.
ted and treated as described in (A) were lysed at 48 hpi and the lysate was
ined by quantifying Hsp60 levels normalized to GAPDH.
emoval of Nutlin-3. HUVECswere treatedwith 10 mMNutlin-3 and infectedwith
t the indicated time points after removal of Nutlin-3. Scale bar, 20 mm.
ECs were treated with 10 mM of Nutlin-3 and infected with C. trachomatis (C.tr.)
um at 16 hpi (lane 4). Cells of the primary infection were lysed and supernatants
lls.
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Chlamydia after etoposide and Nutlin-3 treatment was further
enhanced after G6PD overexpression in a p53 null background
(Figures 5F and S4C), demonstrating that p53-independent
effects have to be considered. Since G6PD has been shown to
have a protective role during oxidative DNA damage (Pandolfi
et al., 1995), we verified the level of etoposide-mediated DNA
damage in the presence of transient expression of G6PD (Fig-
ure S4D) in p53/ cells. We observed considerably less DNA
fragmentation in the presence of G6PD, underlining the protec-
tive potential of the PPP against oxidative stress and DNA dam-
age. In line with this, chlamydial growth was rescued in p53+/+
MEFs after G6PD overexpression in the presence of Nutlin-3.
Chlamydial recovery was further improved after overexpression
of G6PD in p53/ MEFs (Figure S4E).
To further investigate the impact of oxidative stress on the
p53-dependent effects during infection, we measured the levels
of reactive oxygen species (ROS) in p53+/+ and p53/ cells.
ROS levels increased after Nutlin-3 treatment of p53+/+ cells,
but not after etoposide treatment or p53 overexpression (Fig-
ure S5A). In line with these results, antioxidants quenching
ROS failed to rescue chlamydial progeny formation (Figure S5B).
Our results show that p53 degradation serves an important
function during Chlamydia infection to remove the inhibitory
block on G6PD and highlight the importance of the PPP itself,
not only for DNA repair but also for providing the necessary me-
tabolites for optimal chlamydial growth.
DISCUSSION
Obligate intracellular pathogenic bacteria represent a group of
bacteria that live in a special conflict situation because they
entirely depend on metabolites of the host but at the same
time harm the cell. In the case of Chlamydia, the dramatically
reduced genome size and the resulting limited coding capacity
forces the bacteria to receive key metabolites, such as amino
acids and nucleotides, from the host cell. Rapid replication to
more than 1,000 bacteria per cell is certainly one of the most
harmful and stressful insults to the host cell during infection,
but, intriguingly, is not the only one. Like many other bacteria,
Chlamydia induces the formation of ROS early in infection (Bon-
compain et al., 2010). However, in contrast to other bacteria,
increased ROS production at early infection time points andFigure 5. p53 Downregulation and G6PD-Mediated DNA Repair Activit
(A) HUVECs were treated for 1 hr with 6-aminonicotinamide (6-AN) at different c
Chlamydial development was monitored by an infectivity assay and quantificatio
(B) Overexpression of p53 is sufficient to inhibit chlamydial development and inclu
into p53/ H1299 cells and 24 hr later the cells were infected with C. trachoma
infections by quantification of cHsp60.
(C) Overexpression of wild-type p53 prevents inclusion formation. Transfection o
Transfection of HA-p53 did not affect cell viability (c) but prevented inclusion for
(D) G6PD activity after C. trachomatis infection and etoposide treatment. H1299,
were infected with C. trachomatis (C.tr.) or pretreated with etoposide (50 mM) fo
activity was measured. The graph shows mean values ± SEM of two experiment
(E) Chlamydial infectivity can be rescued despite p53 stabilization by overexpr
construct for 24 hr, treated with etoposide for 6 hr, and infected with C. trachom
(F) G6PD overexpression rescues chlamydial infectivity in p53/ H1299 cells. H
poside, infected with C. trachomatis (C.tr.), and subsequently analyzed for chlam
See also Figures S4 and S5.
Cstrong ROS scavenging at later infection time points are essen-
tial for the normal development ofChlamydia (Boncompain et al.,
2010). The dependence on ROS generation that causes severe
genotoxicity (Chumduri et al., 2013) is a paradoxical situation
for an obligate intracellular bacterium that undergoes a develop-
mental cycle and therefore has to protect its replication niche un-
til noninfectious RBs retransform into infectious EBs. Here, we
show that sustained p53 downregulation is the key event that
prevents apoptosis and thus allows the repair of cytotoxic DNA
damage and derepression of the PPP, which is central to host
nucleotide biosynthesis during chlamydial infection.
Previous studies have indicated that many different kinds of
bacterial pathogens, including Chlamydia, can induce severe
DNA damage, particularly DSBs (Bergounioux et al., 2012;
Chumduri et al., 2013; Toller et al., 2011; Vielfort et al., 2013).
DSBs cause some of the most severe insults to DNA because
they lead to a block in the cell cycle and eventually cell death if
not repaired immediately (Nelson and Kastan, 1994). We
observed that Chlamydia infection causes mainly severe short-
ening of telomeres (Prusty et al., 2013). Excessive shortened
telomeres trigger the p53/pRb pathways that induce apoptosis
or senescence to limit the lifespan of the damaged cell (Saretzki
et al., 1999). Interestingly, shortened telomeres were repaired in
infected human cells, but not in mouse cells, pointing to a funda-
mental difference in balancing infection-induced DNA damage.
This was in line with the observation that Chlamydia infectivity
was severely affected in p53 wild-type compared with p53/
mouse cells, implying that p53 plays a central role in counteract-
ing chlamydial development.
Downregulation of the tumor suppressor p53 by Chlamydia
depended on activation of the PI3 kinase/HDM2 pathway, which
controls p53 stability via proteasomal degradation. Interestingly,
PI3 kinase was not significantly activated in mouse cells, sug-
gesting that the activation of this pathway is decisive for the
fate of p53 and the development of Chlamydia. This is in line
with previous reports demonstrating that inhibitors of the PI3 ki-
nase prevent normal chlamydial development (Rajalingam et al.,
2008). However, we found that not only was downregulation of
p53 crucial for Chlamydia to overcome the DNA-damage-driven
cytotoxic response, but stabilization of p53 by etoposide or
Nutlin-3 treatment at early time points of infection dramatically
affected the development and progeny formation of Chlamydia.y Are Critical for Chlamydial Development
oncentrations (1, 5, and 10 mM), followed by C. trachomatis (C.tr.) infection.
n of cHsp60.
sion formation. HA-tagged wild-type p53 construct was transiently transfected
tis (C.tr.). Chlamydial development was monitored in primary and secondary
f empty vector (EV) had no adverse effect on chlamydial development (b; C.tr.).
mation (d). Scale bar, 40 mm.
H1299 transfected with HA-tagged p53, p53 R175H, and R273H H1299 cells
r 6 hr, followed by Chlamydia infection. Samples were processed and G6PD
s performed in triplicate. *p < 0.05, **p < 0.01.
ession of G6PD. HUVECs were transfected with an Myc-DDK-tagged G6PD
atis (C.tr.) for 48 hr.
1299 cells were transfected with Myc-DDK-tagged G6PD, treated with eto-
ydial infectivity.
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These results show that stabilized p53 can function to limit the
growth of intracellular bacteria.
In recent years, p53 has also been linked to regulation ofmeta-
bolism (Vousden and Ryan, 2009). In fast-replicating cancer
cells, metabolism is shifted toward aerobic glycolysis to support
mass and energy production, which is known as the Warburg
effect (Warburg, 1956). As p53 is among the most important in-
hibitors of glycolysis in tumor cells, its inhibition enhances the
Warburg effect. As for tumor cells, directing metabolic pathways
to aerobic glycolysis and the PPP would also be beneficial for
chlamydial growth since they entirely depend on the uptake of
amino acids and nucleotides from the host (Eisenreich et al.,
2013). The importance of an intact PPP for the biosynthesis of
NADPH and other nucleotides is also underlined by the strong in-
duction of nonreplicative chlamydial persistence upon silencing
of G6PD (Prusty et al., 2012). G6PD deficiency is associated with
an increased sensitivity for apoptosis induction by oxidative
stress (Efferth et al., 1995) or ionizing radiation (Tuttle et al.,
2000), suggesting that G6PD is involved in the response to
DSBs. In p53/ cells, ectopic expression of p53 potently in-
hibited G6PD expression and thus the PPP. Because this
pathway has antioxidant properties and provides nucleotide pre-
cursors, it protects against DNA damage and supports DNA
repair. Thus, Chlamydia infections, which inevitably induce the
formation of ROS and DNA damage, are more efficient when
the p53-mediated restriction of the PPP is avoided. Since
G6PD overexpression is sufficient to overcome the p53-depen-
dent and -independent inhibition of chlamydial development, we
conclude that enhanced activity of the PPP as a consequence of
p53 downregulation is the main benefit for Chlamydia.
Downregulation of p53 by bacterial infection has been
previously demonstrated for the free-living bacteriaShigella (Ber-
gounioux et al., 2012),Helicobacter (Wei et al., 2010), andNeisse-
ria (Vielfort et al., 2013). Infectionby the latter twobacteria induces
DNA DSBs that would unavoidably activate p53 and eventually
cause cell death. Recently, Chumduri et al. (2013) demonstrated
that C. trachomatis also induces DNA DSBs at late time points
during infection. Therefore, it is likely that downregulation of p53
is a generalmechanism that enables bacterial pathogens to avoid
the genotoxic response evoked by some bacterial infections. In
contrast to free-living bacteria, however, obligate intracellular
bacteria depend on the metabolites that they take up from the
host cell. Therefore, we suggest that the downregulation of p53
during Chlamydia infection primarily serves to unleash the PPP
shunt. Based on the data presented here, we propose that the tu-
mor suppressor p53 plays an important role in inhibiting the
growth and development of obligate intracellular Chlamydia by
limiting metabolite flow through the PPP.EXPERIMENTAL PROCEDURES
Infectivity Assay
C. trachomatis-infected cells (48 hpi) and uninfected control cells were washed
oncewithPBSand lysedmanuallybyglassbeads.A secondset of cells, seeded
the day before, were infected by one-hundredth of the cell lysate containing in-
fectious EBs, incubated for 24 hr at 35C, and lysed for immunoblot analysis or
fixed with 4% paraformaldehyde for immunostaining. After fixation, cells were
permeabilized with PBS/0.2% Triton X-100 for 15 min at room temperature
(RT) and blocked with PBS/10% fetal bovine serum for 1 hr at RT. After incuba-928 Cell Reports 9, 918–929, November 6, 2014 ª2014 The Authorstion with primary antibody against chlamydial Hsp60 (cHsp60) in PBS/2% fetal
bovine serumatRT for 1 hr, cells were stainedwithCy3-labeled secondary anti-
body for 1 hr in the dark. Cell nuclei were stained with DAPI together with the
secondary antibody. Coverslips were washed and mounted with Mowiol (Carl
Roth) on glass slides. The number of inclusions was determined by counting
ten random fields using an epifluorescencemicroscope (Leica) at 403magnifi-
cation. For confocal laser scanningmicroscopy, sampleswere analyzedusing a
Leica TCS SPE. Infectivity was also determined by quantifying chlamydial
Hsp60 (cHsp60) by immunoblotting. The hfimb cells were obtained and used
according to the guidelines of the local ethics committee.
Cell Transfections
Transfections were performed using Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s protocol. For overexpression of G6PD, cells were
seeded into a 12-well plate and transfected with pCMV6-Myc-DDK-G6PD or
empty vector control. p53 overexpression was achieved by transfecting
pCDNA3-HA-p53 (Marin et al., 2000). One day after transfection, cells were
treated with etoposide (50 mM) for 6 hr or Nutlin-3 (10 mM) for 1 hr and infected
with C. trachomatis for 40 hr, followed by an infectivity assay.
Electron Microscopy
Cells were grown on glass coverslips, fixed for 45 min with 2.5% glutaralde-
hyde (50 mM sodium cacodylate [pH 7.2]; 50 mM KCl; 2.5 mM MgCl2) at RT,
incubated for 2 hr at 4C with 2% OsO4 buffered with 50 mM sodium cacody-
late (pH 7.2), washed with dH2O, and incubated overnight at 4
C with 0.5%
uranyl acetate (in dH2O). The cells were dehydrated, embedded in Epon812,
and ultrathin sectioned at 50 nm. Sections were stainedwith 2%uranyl acetate
in ethanol followed by staining with lead citrate, and analyzed on a Zeiss EM10
microscope (Zeiss).
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